510(k) K222683
K222683 is an FDA 510(k) premarket notification submitted by Nesa Medtech Private Limited for the device "Fibroid Mapping Reviewer Application (FMRA)". The FDA issued a decision of Substantially Equivalent on July 17, 2023. The device falls under product code LLZ (System, Image Processing, Radiological), a Class II device regulated under 21 CFR 892.2050.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 17, 2023
- Date Received
- September 6, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Image Processing, Radiological
- Device Class
- Class II
- Regulation Number
- 892.2050
- Review Panel
- RA
- Submission Type